TAK
Takeda Pharmaceutical Company Limited
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · JP
$19.61
−0.31%Forward multiples
Based on analyst estimates
- P/E forward
- 25.60x
- P/E 2026E
- 50.16x
- P/E 2027E
- 31.30x
- P/E 2028E
- 25.57x
- P/S forward
- 2.11x
Trailing multiples
Trailing twelve months
- P/E TTM
- 53.78x
- PEG TTM
- 0.49x
- Price / book
- 1.31x
- Price / sales
- 2.12x
- Price / cash flow
- 10.37x
Enterprise value
- Enterprise value
- $90.6B
- EV / sales
- 3.07x
- EV / EBITDA
- 11.06x
- EV / EBIT
- 27.94x
- Market cap
- $62.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026